Crossmark

Real-time quantification of the transmission advantage associated with a single mutation in pathogen genomes: a case study on the D614G substitution of SARS-CoV-2

Crossref DOI link: https://doi.org/10.1186/s12879-021-06729-w

Published Online: 2021-10-07

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Shi

Lou, Jingzhi

Cao, Lirong

Zheng, Hong

Chong, Marc K. C.

Chen, Zigui

Chan, Renee W. Y.

Zee, Benny C. Y.

Chan, Paul K. S.

Wang, Maggie H.
Funding

Funding for this research was provided by:

Health and Medical Research Fund (INF-CUHK-1)
License Information

Text and Data Mining valid from 2021-10-07

Version of Record valid from 2021-10-07
More Information

Article History

Received: 7 May 2021

Accepted: 20 September 2021

First Online: 7 October 2021

Declarations

:

: The COVID-19 number of cases and sequencing data are collected via public domains, and thus neither ethical approval nor individual consent is applicable.

: Not applicable.

: MHW is a shareholder of Beth Bioinformatics Co., Ltd. BCYZ is a shareholder of Beth Bioinformatics Co., Ltd and Health View Bioanalytics Ltd. Other authors declared no competing interests.

Document is current

Any future updates will be listed below